BioXell announces change in management
This article was originally published in Scrip
BioXell (Italy) has announced that its chief medical officer, Enrico Colli, has resigned in order to pursue a career at a large pharmaceutical organisation. He is expected to leave the company at the end of September. BioXell's chief executive officer, Francesco Sinigaglia, will take over the responsibility for his function on an interim basis until a successor is appointed.